AAAAAA

   
Results: 1-8 |
Results: 8
Non-myeloablative hematopoietic stem cell transplantation
Authors: Maris, M Sandmaier, BM Maloney, DG McSweeney, PA Woolfrey, A Chauncey, T Shizuru, J Niederwieser, D Blume, KG Forman, S Storb, R
Citation: M. Maris et al., Non-myeloablative hematopoietic stem cell transplantation, TRANSF CL B, 8(3), 2001, pp. 231-234
Nonmyeloablative hematopoietic stem cell transplantation: Transplantation for the 21(st) century
Authors: Maris, M Woolfrey, A McSweeney, PA Sandmaier, BM Nash, RA Georges, G Maloney, DG Molina, A Chauncey, T Yu, C Zaucha, JM Blume, KG Shizuru, J Niederwieser, D Storb, R
Citation: M. Maris et al., Nonmyeloablative hematopoietic stem cell transplantation: Transplantation for the 21(st) century, FRONT BIOSC, 6, 2001, pp. G13-G16
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters
Authors: Storb, R Blume, KG O'Donnell, MR Chauncey, T Forman, SJ Deeg, HJ Hu, WW Appelbaum, FR Doney, K Flowers, MED Sanders, J Leisenring, W
Citation: R. Storb et al., Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters, BIOL BLOOD, 7(1), 2001, pp. 39-44
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia
Authors: Jurado, M Deeg, HJ Gooley, T Anasetti, C Chauncey, T Flowers, MED Myerson, D Storb, R Appelbaum, FR
Citation: M. Jurado et al., Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, BR J HAEM, 112(2), 2001, pp. 392-396
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation
Authors: Radich, JP Gooley, T Bryant, E Chauncey, T Clift, R Beppu, L Edmands, S Flowers, MED Kerkof, K Nelson, R Appelbaum, FR
Citation: Jp. Radich et al., The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation, BLOOD, 98(6), 2001, pp. 1701-1707
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis
Authors: Anderson, JE Tefferi, A Craig, F Holmberg, L Chauncey, T Appelbaum, FR Guardiola, P Callander, N Freytes, C Gazitt, Y Razvillas, B Deeg, HJ
Citation: Je. Anderson et al., Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis, BLOOD, 98(3), 2001, pp. 586-593
Second allogeneic transplantation after failure of first autologous transplantation
Authors: Radich, JP Gooley, T Sanders, JE Anasetti, C Chauncey, T Appelbaum, FR
Citation: Jp. Radich et al., Second allogeneic transplantation after failure of first autologous transplantation, BIOL BLOOD, 6(3), 2000, pp. 272-279
Allogeneic hematopoietic stem cell transplantation: From the nuclear age into the twenty-first century
Authors: Storb, R McSweeney, PA Sandmaier, BM Nash, RA Georges, G Maloney, DG Molina, A Chauncey, T Yu, C Zaucha, JM Blume, KG Shizuru, J Niederwieser, D
Citation: R. Storb et al., Allogeneic hematopoietic stem cell transplantation: From the nuclear age into the twenty-first century, TRANSPLAN P, 32(7), 2000, pp. 2548-2549
Risultati: 1-8 |